This inventor holds 1 USPTO granted patent. Top assignee: Flexion Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mark Douglas: Innovator in Biological Delivery Systems
Introduction
Mark Douglas is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of biological delivery systems, particularly in the treatment of osteoarthritis in humans. His innovative approach has the potential to improve patient outcomes and advance medical treatments.
Latest Patents
Mark Douglas holds a patent titled "Effective Dosages of an Adenoviral-Based Biological Delivery and Expression System for Use in the Treatment of Osteoarthritis in Humans, and Compositions Comprising the Same." This patent represents his commitment to developing effective therapies for osteoarthritis, showcasing his expertise in the field.
Career Highlights
Mark Douglas is currently associated with Flexion Therapeutics, Inc., where he continues to work on groundbreaking research and development. His role at the company allows him to collaborate with other experts in the field and contribute to innovative solutions for patients suffering from osteoarthritis.
Collaborations
Mark has worked alongside talented colleagues such as Scott Kelley and Rebecca Senter. Their combined efforts in research and development have fostered a collaborative environment that encourages innovation and progress in the medical field.
Conclusion
Mark Douglas is a dedicated inventor whose work in biological delivery systems is paving the way for advancements in osteoarthritis treatment. His contributions to the field are invaluable, and his ongoing research promises to enhance the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile